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Objective: Trauma-focused psychological treatments are recommended as ﬁrst-line treatments for
Posttraumatic Stress Disorder (PTSD), but clinicians may be concerned that the good outcomes observed
in randomized controlled trials (RCTs) may not generalize to the wide range of traumas and pre-
sentations seen in clinical practice. This study investigated whether Cognitive Therapy for PTSD (CT-PTSD)
can be effectively implemented into a UK National Health Service Outpatient Clinic serving a deﬁned
ethnically mixed urban catchment area.
Method: A consecutive sample of 330 patients with PTSD (age 17e83) following a wide range of traumas
were treated by 34 therapists, who received training and supervision in CT-PTSD. Pre and post treatment
data (PTSD symptoms, anxiety, depression) were collected for all patients, including dropouts. Hierar-
chical linear modeling investigated candidate moderators of outcome and therapist effects.
Results: CT-PTSD was well tolerated and led to very large improvement in PTSD symptoms, depression
and anxiety. The majority of patients showed reliable improvement/clinically signiﬁcant change: intent-
to-treat: 78.8%/57.3%; completer: 84.5%/65.1%. Dropouts and unreliable attenders had worse outcome.
Statistically reliable symptom exacerbation with treatment was observed in only 1.2% of patients.
Treatment gains were maintained during follow-up (M ¼ 280 days, n ¼ 220). Few of the selection criteria
used in some RCTs, demographic, diagnostic and trauma characteristics moderated treatment outcome,
and only social problems and needing treatment for multiple traumas showed unique moderation ef-
fects. There were no random effects of therapist on symptom improvement, but therapists who were
inexperienced in CT-PTSD had more dropouts than those with greater experience.
Conclusions: The results support the effectiveness of CT-PTSD and suggest that trauma-focused cognitive
behavior therapy can be successfully implemented in routine clinical services treating patients with a
wide range of traumas.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.A substantial number of randomized controlled trials (RCTs)
have established the efﬁcacy of trauma-focused cognitive behav-
ioral treatments (TF-CBT) in posttraumatic stress disorder (PTSD)tal Psychology, University of
þ44 1865 618600.
s).
r Ltd. Open access under CC BY licens(for reviews see Australian Centre for Posttraumatic Mental Health,
2007; Bisson et al., 2007; Bradley, Greene, Russ, Dutra, & Westen,
2005; Kitchner, Roberts, Wilcox, & Bisson, 2012; Powers, Halpern,
Ferenschak, Gillihan, & Foa, 2010; Stein et al., 2009). These RCTs
have shown very large effect sizes in treating PTSD symptoms and
associated symptoms of depression and anxiety for a range of TF-
CBT programs. There is as yet less evidence on how effective such
treatment programs are when applied in routine clinical settings.
Clinicians are often concerned that that the good outcomes
observed in RCTs may not generalize to the wide range of traumas
and presentations seen in clinical practice.e.
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clinical care?
Several factors are conceivable that could potentially limit the
extent to which the treatment effects observed in RCTs generalize
to patients seen in routine clinical practice. Although most RCTs
studied clinically pertinent samples with moderate to severe PTSD
and associated comorbid conditions, they applied certain inclusion
and exclusion criteria. The selection may inﬂuence outcome, for
example, by increasing the average size of improvement by
requiring a minimum severity or by excluding difﬁcult-to-treat
patients. One of these potential factors is that many RCTs selected
patients who suffered from discrete traumas such as physical or
sexual assault or trafﬁc accidents (but may have also experienced
additional other traumas, e.g., Bryant, Moulds, Guthrie, Dang, &
Nixon, 2003; Ehlers et al., 2003; Foa et al., 2005; Resick, Nishith,
Weaver, Astin, & Feuer, 2002; Schnurr et al, 2007), whereas in
clinical practice patients may require treatment for wider range of
traumas including prolonged and multiple traumatic events. It re-
mains unclear whether the exclusion of certain demographic
groups such as men, people older than 65 years of age, or comorbid
conditions such as borderline personality disorder inﬂuences the
overall treatment effects. Second, there have been concerns about a
possible risk of symptom exacerbation with exposure to trauma
memories (e.g., Tarrier et al., 1999). Although initial reports have
found symptom exacerbation to be uncommon in RCT samples (e.g.,
Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002; Hackmann,
Ehlers, Speckens, & Clark, 2004), clinicians may be concerned that
this problem may be more common in patients seen in routine
clinical care. A third concern relates to treatment dropouts. Many of
the earlier RCTs reported completer-only analyses. If dropout rates
are substantial, completer analyses may overestimate the efﬁcacy
of treatments. Some RCTs have observed high dropout rates of
between 25 and 43% with trauma-focused PTSD treatments in RCTs
(e.g., Foa et al., 2005; Power et al., 2002; Resick et al., 2002; Schnurr
et al, 2007), although the average dropout rate may not be higher
than for other PTSD treatments (Hembree et al., 2003). Fourth, in
RCTs treatment is usually delivered by therapists who receive
specialized training and supervision in TF-CBT, and clinicians with
less training and supervision may ﬁnd it difﬁcult to replicate their
results. Thus, there is a need to empirically investigate howwell the
excellent outcomes of TF-CBT observed in RCTs can be replicated in
routine clinical settings where patients are not selected for RCT
suitability and treatment is delivered by therapists with a range of
prior experience with TF-CBT.
Preliminary evidence suggests that TF-CBT programs can be
successfully implemented in routine clinical services (for reviews
see Cohen & Mannarino, 2008; Stewart & Chambless, 2009). Foa
et al.’s (2005) RCT of Prolonged Exposure for sexual assault survi-
vors found equivalent outcomes for expert therapists and newly
trained therapists working in a community center. Karlin et al.
(2010) reported that veterans treated with Prolonged Exposure or
Cognitive Processing Therapy following an extensive therapist
training program implemented in the Veteran Health Administra-
tion showed a 30% decrease in PTSD symptoms in completer ana-
lyses (see also Monson et al., 2006; Tuerk et al., 2011). Levitt, Malta,
Martin, Davis, and Cloitre (2007) and Brewin et al. (2010) reported
large improvements in outreach programs for survivors of 9/11 and
the London bombings who suffered from PTSD.
Gillespie, Duffy, Hackmann, and Clark (2002) trained therapists
from a range of professional backgrounds in Cognitive Therapy for
PTSD, a version of TF-CBT that builds on Ehlers and Clark’s (2000)
model of PTSD. The therapists treated an unselected group of pa-
tients seeking treatment for PTSD after the Omagh bombing in
Northern Ireland and achieved similarly good outcomes as thoseobserved in RCTs. Duffy, Gillespie, and Clark (2007) further suc-
cessfully disseminated this treatment to an unselected group of
patients who had experienced traumas in connection with the civil
conﬂict in Northern Ireland, the majority of whom had experienced
multiple traumatic events.
Whilst these initial studies evaluating the effectiveness of TF-
CBT for PTSD are promising, they are limited in number, and
further studies of larger samples of unselected patients with PTSD
following the wide range of traumatic events seen in clinical set-
tings are needed to determine the effectiveness of TF-CBT pro-
grams. The present study describes treatment outcomes of
consecutive referrals to a National Health Service outpatient clinic
treated with CT-PTSD. The clinic was newly opened in April 2001
and thus provided an opportunity to train new therapists in
delivering this treatment, and to study treatment effectiveness,
moderators of treatment outcome and possible therapist effects in
a consecutive patient sample from a deﬁned catchment area.Moderators of treatment effectiveness
The study investigated candidate moderators of the effective-
ness of TF-CBT in routine clinical settings. We were interested in
whether selection criteria for randomized controlled trials actually
predict treatment response, and whether other aspects of clinical
history, comorbidity or trauma history moderate treatment
outcome. Kraemer, Wilson, Fairburn, and Agras (2002) distinguish
two types of predictors of outcome. Nonspeciﬁc predictors of
outcome inﬂuence the overall severity of symptoms, but do not
inﬂuence the slope of treatment-induced improvement. Some TF-
CBT studies have correlated candidate predictors with symptom
severity at the end of therapy and have generally found that pa-
tients with more severe symptoms of PTSD and depression at the
beginning of treatment have more remaining symptoms at the end
of treatment (e.g., Blanchard et al., 2003; van Emmerik, Kamphuis,
Noordhof, & Emmelkamp, 2011; van Minnen, Arntz, & Keijsers,
2002; Schulz, Resick, Huber, & Grifﬁn, 2006). A moderator of
treatment effectiveness is a variable that inﬂuences the slope of
improvement (Kraemer et al., 2002). Several studies of TF-CBT
attempted to identify moderators of treatment response in RCTs
(e.g., Ehlers, Clark, Hackmann, McManus, & Fennell, 2005; Feeny,
Zoellner, & Foa, 2002; Kubany et al., 2004; Rizvi, Vogt, & Resick,
2009; Tarrier, Sommerﬁeld, Pilgrim, & Faragher, 2000; van
Emmerik et al., 2011) and routine clinic samples (e.g., Gillespie
et al., 2002; Richardson, Elhai, & Sareen, 2011; Rosenkranz &
Muller, 2011; van Minnen et al., 2002). The results were often
inconsistent and few moderators have been identiﬁed. Variables
that were shown in some studies to be associated with less favor-
able treatment response included
 demographic variables such as male sex (Blain, Galovski, &
Robinson, 2010), younger age (Rizvi et al., 2009; Taylor,
Fedoroff, & Koch, 1999), higher level of education (Ehlers et al.,
2005) or ethnic minority (Walling, Suvak, Howard, Taft, &
Murphy, 2012);
 comorbidity with other anxiety disorders or high symptoms of
anxiety and arousal (Rosenkranz & Muller, 2011; Tarrier et al.,
2000; but see van Minnen et al., 2002; Richardson et al., 2011;
for negative ﬁndings); with depression or suicidal ideation (Duffy
et al., 2007; Tarrier et al., 2000; but see van Minnen et al., 2002;
Richardson et al., 2011; for negative ﬁndings); substance abuse
(van Minnen et al., 2002; but see Richardson et al., 2011; for
negative ﬁndings); personality disorders (Clarke, Rizvi, & Resick,
2008; Feeny et al., 2002); use of psychotropic medication (van
Minnen et al., 2002), and permanent physical disability
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et al., 2007; for negative ﬁndings);
 trauma characteristics such as multiple trauma (van Minnen
et al., 2002), childhood trauma (van Minnen et al., 2002; but
also see Jaycox, Foa, & Morral, 1998; for negative ﬁndings),
interpersonal trauma committed by a perpetrator (van Minnen
et al., 2002), longer time since the trauma (Duffy et al., 2007;
but see Ehlers et al., 2005; Rizvi et al., 2009; for negative
ﬁndings).Fig. 1. Patient ﬂow.Therapist effects
In a meta-analysis of psychotherapy outcome studies, Crits-
Christoph et al. (1991) found that on average 8.6% of the variance
in outcome were due to random therapist effects. Greater therapist
effects were found when no treatment manual was used and
therapists were inexperienced. More recent studies are consistent
with this pattern of results. Wampold and Brown (2005) estimated
that about 5% of the variation in outcome of 6146 patients with
different diagnoses treated in managed care was due to therapists.
Similarly, Lutz, Leon, Martinovich, Lyons, and Stiles (2007) inves-
tigated outcomes of patients in managed care treated by therapists
of different professional backgrounds and orientations and esti-
mated that 8% of the variance in outcome could be attributed to
therapists. Other recent studies investigated more homogeneous
samples of clients with a particular disorder who were treated
according to a particular protocol and found no signiﬁcant effects of
therapist on outcome (e.g., Cella, Stahl, Reme, & Chalder, 2011;
Wilson, Wilﬂey, Agras, & Bryson, 2011). In PTSD, there is as yet
little data on therapist effects. In RCTs, Ehlers et al. (2003, 2005, see
Baldwin et al., 2011) and Kubany et al. (2004) found no therapist
effects, while Duffy et al. (2007) reported signiﬁcantly worse
outcome for one therapist who was inexperienced in delivering the
treatment protocol.
Aims of the study
This study had the following aims:
(1) to assess the effectiveness of CT-PTSD in unselected patients
referred to a National Health Service outpatient clinic,
(2) to assess treatment response of patients who do not com-
plete treatment,
(3) to investigate whether candidate diagnostic variables, de-
mographic variables and aspects of trauma history moderate
treatment response, and
(4) to explore therapist effects on treatment outcome.Method
Clinical setting and patients
The Centre for Anxiety Disorders and Trauma, Maudsley Hos-
pital, UK, is an outpatient clinic specializing in the treatment of
anxiety disorders in adults. It was opened in April 2001 and is part
of the British National Health Service, receiving referrals from
General Practitioners and Community Mental Health Teams. The
clinic offers assessment and treatment for survivors of trauma in
adulthood who suffer from PTSD. It serves a population of about
867,000 people living in the South London Boroughs of Southwark,
Lewisham and Lambeth. These areas have substantially higher rates
of social deprivation, crime, and a greater proportion of ethnic
minorities than the UK average.The present study included all consecutive patients who were
referred for assessment for possible PTSD between April 2001 and
August 2008. The study was approved by the local research ethics
committee. Fig. 1 shows that 577 patients completed the assess-
ment, and 408 were suitable for trauma-focused treatment. The
main reasons for not being suitable at the time of assessment were
that the patient did not have PTSD (n ¼ 42), or ﬁrst needed treat-
ment for another primary problem such as alcohol dependence or
immediate suicide risk (n ¼ 73). The main reasons for not being
offered CT-PTSD despite suitability for treatment (n¼ 78) were that
the patient did not want treatment (n¼ 27) or participated in a trial
where they received another psychological treatment (n ¼ 21). A
total of 330 patients were offered a course of CT-PTSD. Data for
initial assessment and the last treatment session were available for
all patients, including dropouts. Two thirds (n¼ 220) of the patients
provided follow-up data.
Fifty-six percent (n ¼ 185) of the 330 patients in the intent-to-
treat sample were female. Their ages ranged from 18 to 83 years,
M¼ 38.8, SD ¼ 11.5. A large proportion (43.7%) of the patients were
from ethnic minorities, and either unemployed (33.7%), or on
disability/retired (8.7%) or sick leave (16.0%) because of their
symptoms. The majority (42.8%) was single, 37.7% were married/
cohabitating with a partner, and 19.5% were divorced/widowed.
The majority (43.8%) had completed mandatory school education
up to age 16 (GCSE or equivalent), 18% had not completed school
exams, 15% had taken higher school exams at age 18 (A level), and
23.2% had attended university.
The most common type of trauma addressed in treatment was
interpersonal violence (including physical assault, sexual assault,
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disaster (22.4%), traumatic death/harm to others (9.5%), and other
traumas (11.2%). In 22.5% of patients, the trauma had involved the
death of another person. The main traumas that were addressed in
treatment had happened between 3 and 360months ago,M¼ 36.5,
SD ¼ 56.9. Most patients (82.0%) had been injured during their
traumas, and 21.5% had suffered permanent physical disabilities or
loss of function due to the trauma. A third of the patients (33.7%)
had received previous treatment for their PTSD, and 9.1% had had a
previous course of trauma-focused CBT. The majority (63.0%) re-
ported a history of further traumas, and 17.8% reported a history of
childhood abuse.
Comorbidity with other disorders was common; 75.8% met
diagnostic criteria for at least one current comorbid Axis 1 disor-
ders, and 29.1% met criteria for Axis II disorders. The most common
comorbid Axis 1 conditions were mood disorders (50.9%), other
anxiety disorders (42.7%) and substance abuse (22.1%). Nearly half
(48.5%) reported current suicidal ideation, and 14.2% reported past
suicide attempts. A history of major depression was common
(69.7%), and a signiﬁcant minority (18.8%) reported a history of
substance dependence. The mean number of comorbid disorders
was 2.2, SD ¼ 2.1.
Patients taking psychotropic medication (n ¼ 132, 40.0%) were
asked to remain on a stable dose for two months before treatment
started and to stay on the same dose for the duration of treatment,
and themajority of patients reported that they followed this advice.
The majority (54.5%) of these patients were taking SSRIs, 16.3%
tricyclic antidepressants, 4.9% benzodiazepines, 6.5% hypnotics.
and 17.9% other medication.
Patients who provided follow-up data (n ¼ 220) were compa-
rable to those who did not (n ¼ 110) on most demographic, diag-
nostic and trauma history characteristics, but had higher education
levels, c2 (3, n ¼ 306) ¼ 11.91, p ¼ .008; were more likely to be
employed, c2 (1, n ¼ 312) ¼ 4.91, p ¼ .027, and less likely to have
comorbid mood disorders, c2 (1, n ¼ 330) ¼ 14.77, p < .001, current
substance abuse, c2 (1, n ¼ 330) ¼ 5.62, p < .018, or personality
disorders, c2 (1, n ¼ 330) ¼ 4.99, p ¼ .025.
Therapists
Therapists included both qualiﬁed clinicians and therapists in
training. A total of 34 different therapists with a wide range of prior
experience in CBT treated patients during the study period. This
included clinical psychologists (qualiﬁed n ¼ 15, 44.1%;
trainees ¼ 11, 32.3%), nurse therapists (n ¼ 3, 8.8%) and psychia-
trists (trainees, n ¼ 5, 14.7%). Each therapist participated in a two-
day workshop in CT-PTSD. They then received close individual su-
pervision in treating their ﬁrst few cases and had the opportunity to
act as co-therapists with a trained therapist for at least one case.
Thereafter, cases were discussed in weekly CT-PTSD focused group
supervision. Data for all patients including training cases were
included in the data analysis. Two aspects of therapist experience
were coded: ﬁrst, whether the therapist was a trainee or a staff
therapist, and second, the therapists’ experience with CT-PTSD
(experienced was deﬁned as having treated more than 12 pa-
tients with CT-PTSD).
Treatment
CT-PTSD is based on Ehlers and Clark’s (2000) model of PTSD
and targets three factors speciﬁed in this model. It is suggested that
people with PTSD perceive a serious current threat which has two
sources, excessively negative appraisals of the trauma and/or its
sequelae and characteristics of trauma memories that lead to
reexperiencing symptoms. The problem is maintained by cognitivestrategies and behaviors (such as thought suppression, rumination,
and safety-seeking behaviors) that are intended to reduce the sense
of current threat, but maintain the problem by preventing change
in the appraisals or trauma memory, and/or by increasing symp-
toms. Details of the treatment procedures are found in Clark and
Ehlers (2004), Ehlers et al. (2005) and Ehlers et al. (2010, http://
oxcadat.psy.ox.ac.uk/downloads/CT-PTSD%20Treatment%
20Procedures.pdf/view). Treatment was conducted in English in
individual treatment sessions. Patients received a mean ofM¼ 10.6
weekly treatment sessions, SD ¼ 5.0, andM ¼ 2.0 monthly booster
sessions, SD ¼ 3.0, similar to previous trials (Ehlers et al., 2003,
2005). Therapists kept detailed notes about each treatment ses-
sion, and an independent rater rated the extent to which the ses-
sion focused on the PTSD treatment model, on a scale from 1 to 3
(1 ¼ mainly followed trauma-focused protocol, 2 ¼ equal focus on
trauma-focused protocol and other problems, 3 ¼main focus on other
problems). The mean rating for all sessions wasM¼ 1.35, SD ¼ 0.39,
and for 90.1% of the patients treatment mainly focused on the PTSD
treatment protocol (mean rating of below 2). The most common
other problems addressed in the sessions were comorbid disorders,
and other stressors such as social problems (e.g., ﬁnancial, housing,
legal issues) or physical health problems.
Measures
Self-reports of symptom severity were taken at initial assess-
ment, at the ﬁrst and last treatment session, and at follow-up
(mean 280 days).
Severity of PTSD symptoms
The primary outcome measure was the change in PTSD symp-
toms. Patients completed the Posttraumatic Diagnostic Scale (PDS,
Foa, Cashman, Jaycox, & Perry, 1997). The PDS asks patients to rate
how often they were bothered by each of the PTSD symptoms
speciﬁed in DSM-IV ranging from 0 ¼ never to 3 ¼ 5 times per week
or more/almost always. The PDS yields a sum score measuring the
overall severity of PTSD symptoms. Foa et al. (1997) showed that
the self-report questionnaire has good reliability and concurrent
validity with other PTSD measures. Internal consistency in this
sample was a ¼ .85.
Depression and anxiety
Symptoms of anxiety and depression were secondary outcome
measures. Patients completed the Beck Anxiety Inventory (BAI,
Beck & Steer, 1993a) and the Beck Depression Inventory (BDI, Beck
& Steer, 1993b), standard 21-item self-report measures with high
reliability and validity. Internal consistencies in this sample were
a ¼ .92 and a ¼ .90, respectively.
Candidate moderators
At initial assessments, clinicians conducted the Structured Clin-
ical Interview for DSM-IV (SCID) to assess Axis I (First, Spitzer,
Gibbon, & Williams, 1996) and II diagnoses (First, Gibbon, Spitzer,
& Williams, 1995). Interrater-reliability for PTSD (determined
from a random selection of 37 audiotapes of the interviews) was
k ¼ 0.95. Clinicians also determined in the interview what the
patient’s main problemwas and assessed physical consequences of
the trauma (disability, chronic pain) and the patients’ treatment
and trauma history (adapted from the Clinician Administered PTSD
Scale, Blake et al., 1995). Patients provided demographic
information.
Table 1
Intent-to-treat treatment outcome for all consecutive patients who were offered
treatment including drop-outs.
Outcome measure and assessment point All patients (N ¼ 330)
M SD
PDS pre treatment 33.98 8.77
End of treatment 17.46 14.37
ES (pre e end, pooled SD) d ¼ 1.39
ES (pre e end, pre SD) d ¼ 1.88
BDI pre treatment 27.33 11.75
End of treatment 15.87 13.42
ES (pre e end, pooled SD) d ¼ 0.91
ES (pre e end, pre SD) d ¼ 0.98
BAI pre treatment 28.39 13.62
End of treatment 14.52 14.92
ES (pre e end, pooled SD) d ¼ 0.97
ES (pre e end, pre SD) d ¼ 1.02
PDS ¼ Posttraumatic Diagnostic Scale (N ¼ 330); BDI ¼ Beck Depression Inventory
(n¼ 320); BAI¼ Beck Anxiety Inventory (n¼ 321); ES¼ Effect Size, d¼ Cohen’s d, SD
¼ standard deviation
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of the literature reviewed above.
1. Selection criteria used in some previous RCTs: male sex; age; pa-
tient does not meet full DSM-IV criteria (American Psychiatric
Association, 1994) and only meets ICD-10 (World Health
Organization, 2010) PTSD criteria; PTSD is not the main prob-
lem (i.e., another disorder is so severe that it needs principal
concurrent treatment in its own right, e.g., very severe depres-
sion or agoraphobia); borderline personality disorder; current
substance abuse; current PTSD is linked to multiple traumas;
history of childhood abuse; no memory for the trauma; patient
had a previous course of trauma-focused CBT for PTSD.
2. Demographic variables: ethnic group; education; social problems
(deﬁned as one or more of unemployment, ﬁnancial hardship,
housing problems); relationship status (never married/lived
with partner vs. married, cohabiting, widowed or divorced);
ongoing legal proceedings, any previous treatment for PTSD.
3. Comorbidity: current comorbid anxiety disorder, mood disor-
ders, other axis 1 disorders, personality disorder, suicidal idea-
tion, taking psychotropic medication; physical disability
resulting from trauma, chronic pain; history of major depres-
sion, substance dependence, or suicide attempts.
4. Aspects of trauma history: Trauma type (interpersonal trauma vs
other); trauma involved death of other person; injured in
trauma; months since main trauma; history of other traumas;
total number of traumas experienced.Treatment variables
Three aspects of the course of treatment were coded from the
session notes to test possible effects of the moderators on treat-
ment delivery.
1. Dropout: This was deﬁned as attending less than 8 sessions,
unless the earlier termination was determined in agreement
with the therapist. This criterion was chosen because UK
treatment guidelines (National Institute for Health and Clinical
Excellence, 2005) recommend 8 sessions as an adequate trial
of trauma-focused treatments for PTSD on the basis of prior
research.
2. Attendance: Therapists indicated in the session notes whether
or not the patient was often late or missed appointments
without notifying the therapist.
3. Trauma focus: the degree to which treatment followed the
trauma-focused PTSD treatment protocol, as above.
Data analysis
Measures of treatment response
The main outcome variable was the change in PDS scores with
treatment. Several further measures of treatment response were
calculated for comparability with previous studies.
Reliable improvement and exacerbation
Reliable change thresholds for the PDS were calculated by Foa
et al. (2002) on the basis of the retest reliability and standard de-
viation of the scale. Reliable improvement and exacerbation are
decreases/increases in PDS scores of greater than 6.15, respectively.
Clinically signiﬁcant treatment response
Clinical signiﬁcant response was deﬁned as in Jacobson and
Truax (1991). Patients had to show a reliable improvement andtheir score at the end of treatment had to be lower than the halfway
point between 2 SD below the patients’ scores at the beginning of
treatment, and 2 SD above themean of a sample of 466 traumatized
people without PTSD from the same catchment area (M ¼ 7.22,
SD ¼ 7.75), i.e., lower than 19.775. This criterion is similar to the
PDS cut-offs between clinical and nonclinical presentations estab-
lished by Ehring, Kleim, Clark, Foa, and Ehlers (2007) on the basis of
agreement with structured diagnostic interviews.
Effect size
Treatment effect sizes for changes in symptom scores between
the pre treatment assessment and ﬁnal treatment session were
calculated using Cohen’s d statistic (Cohen, 1988). As other studies
vary in whether effect sizes are reported in relation to pooled pre-
post standard deviations, or pre-treatment standard deviations, we
report both for comparison.Statistical analysis
The Statistical Package for Social Sciences, version 20, was used
for data analysis. Hierarchical linear modeling investigated the ef-
fect of candidate moderators and therapist effects on the degree of
improvement in the PDS with treatment, following guidelines by
Heck, Thomas, and Tabata (2010). This analysis uses data from all
patients. All variables were centered for this analysis (Kraemer
et al., 2002). At Level 1, the effects of repeated observations nes-
ted within patients were considered. Model 1 modeled the slope of
improvement in PDS scores from pre treatment to post treatment
to follow-up and tested random slopes and intercepts for patients.
Linear and quadratic changes in PDS scores with time were ﬁtted,
using an autoregressive covariance structure at Level 1. At Level 2,
patient characteristics that may inﬂuence outcomewere ﬁrst added
individually (because of some missing data on some of the vari-
ables) to themodel to test for main effects on PDS scores (indicating
nonspeciﬁc prediction of symptom severity, Kraemer et al., 2002)
and interactions with the slope of improvement (moderator effects,
Kraemer et al., 2002). Next, variables that showed signiﬁcant in-
teractions were combined into an overall Model 2 to determine
unique moderators of slope of improvement. At Level 3 (therapist
effects), random slopes and intercepts for therapists were included
in Model 3. In Model 4, the two measures of therapist experience
were added, trainee versus staff therapist and experienced versus
inexperienced in delivering CT-PTSD.
Table 2
Overview of individual candidate predictors of outcome and ﬁxed effects estimates
from hierarchical linear modeling (in points on centered PDS scale).
Predictor Type of effect Size of effect (ﬁxed
effect estimate and
standard error)
Exclusion criteria used in some RCTs
Male sex Not a predictor
Age Not a predictor
Does not meet full DSM-IV criteria Nonspeciﬁc predictor 10.35 (1.68)***
PTSD not main problem Moderator 3.31 (1.21)**
Current substance abuse Nonspeciﬁc predictor 2.50 (1.26)*
Borderline personality disorder Not a predictor
Needs treatment for multiple
traumas
Moderator 4.01 (1.30)**
History of childhood abuse Not a predictor
No memory of trauma Not a predictor
Previous CBT for PTSD Not a predictor
Demographics
Ethnic minority Not a predictor
Lower level of education Nonspeciﬁc predictor 2.78 (1.03)
Social problems Moderator and
Nonspeciﬁc predictor
5.23 (1.02)***
3.76 (0.89)***
No relationship (never married or
living with partner)
Moderator 2.46 (0.93)**
Ongoing legal proceedings Not a predictor
Any previous treatment for PTSD Not a predictor
Comorbidity
Current comorbid anxiety disorder Not a predictor
Current mood disorder Moderator and
Nonspeciﬁc predictor
1.95 (0.92)*
7.00 (0.97)***
Current other axis 1 disorder Nonspeciﬁc predictor 4.73 (1.78)**
Any personality disorder Nonspeciﬁc predictor 2.57 (1.15)*
Current suicidal ideation Nonspeciﬁc predictor 5.92 (0.99)***
Taking psychotropic medication Nonspeciﬁc predictor 5.87 (1.08)***
Chronic pain Nonspeciﬁc predictor 3.08 (1.14)**
Physical disability due to trauma Nonspeciﬁc predictor 2.54 (1.27)*
History of major depression Nonspeciﬁc predictor 5.39 (1.10)***
History of substance dependence Moderator and
Nonspeciﬁc predictor
3.34 (1.19)**
3.48 (1.33)**
Past suicide attempts Moderator and
Nonspeciﬁc predictor
2.96 (1.30)*
3.34 (1.50)*
Trauma History
Main trauma interpersonal Not a predictor
Someone died in main trauma Not a predictor
Injured in trauma Not a predictor
Months since main trauma Moderator 1.06 (0.46)*
History of other traumas Not a predictor
Number of traumas Not a predictor
History of child abuse Not a predictor
Injured in trauma Not a predictor
*p < .05, **p < .01, ***p < .001.
Nonspeciﬁc predictor: predicts symptom levels before and after treatment, but not
treatment response.
Moderator: predicts treatment response.
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Fig. 2. Intent-to-treat outcome for patients who were offered treatment (n ¼ 330).
PDS ¼ Posttraumatic Diagnostic Scale (n ¼ 330); BDI ¼ Beck Depression Inventory
(n ¼ 320); BAI ¼ Beck Anxiety Inventory (n ¼ 321).
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Overall effectiveness of treatment
There was no signiﬁcant change in PTSD symptoms during the
wait period between assessment and treatment, M ¼ 97.1 days,
SD ¼ 77.0, PDS scoresM ¼ 33.88, SD ¼ 8.67 toM ¼ 33.15, SD ¼ 9.25,
F(1, 275) ¼ 2.71, p ¼ .101, d ¼ 0.08.
Table 2 shows the PTSD symptom scores (PDS) at initial
assessment and the last treatment session for the intent-to-treat
sample of 330 patients (see also Fig. 2). Patients received a mean
of 12.57 sessions (SD ¼ 6.51). Patients showed very large
improvement in PTSD symptom severity with treatment. Two
hundred sixty patients (78.8%) showed a reliable improvement (Foaet al., 2002). The mean percent change in PTSD symptoms was
50.4%, SD ¼ 40.38. The majority of patients (n ¼ 189, 57.3%) showed
a clinically signiﬁcant change. Clinically signiﬁcant change was
associated with greater trauma focus of the sessions, M ¼ 1.31,
SD ¼ 0.37 versus M ¼ 1.41, SD ¼ 0.42, F(1, 322) ¼ 5.51, p ¼ .020,
d ¼ 0.17.
In treatment completers, PDS scores decreased fromM ¼ 33.83,
SD ¼ 8.67 to M ¼ 15.18, SD ¼ 13.65, d ¼ 1.63 for pooled SD and
d ¼ 2.15 for pre-treatment SD, and the mean change in PDS scores
was 57.95%, SD ¼ 34.95. A reliable change in PDS scores was
observed in 240 (84.5%) of the completers, and a clinically signiﬁ-
cant change in 185 (65.1%).
Analysis of dropouts and attendance
The overall dropout rate was 13.9%, 46 of 330 patients. Of these,
6 patients (13%) dropped out after 1 session, 11 (23.9%) after 2
sessions, 8 (17.4%) after 3 sessions, 4 (8.7%) after 4 sessions, 7
(15.2%) after 5 sessions, 4 (8.7%) after 6 sessions, and 6 (13.0%) after
7 sessions. Patients who dropped out had waited longer for treat-
ment t (327) ¼ 4.89, p ¼ .005. Among dropouts, only 8.7% (4/46)
showed a clinically signiﬁcant treatment response, compared to
66.9% (190/94) of treatment completers, c2 (1, n ¼ 330) ¼ 55.36,
p < .001.
Twenty-one percent of the patients (n ¼ 71) were classiﬁed as
unreliable attenders. This variable was independent of dropout
status, C ¼ 0.049. Unreliable attenders were less likely to show
clinically signiﬁcant change than patients who attended regularly,
42.3% versus 63.3%, c2 (1, n ¼ 330) ¼ 10.21, p ¼ .001.
Symptom exacerbation
Fourteen patients (4.3%) had reliable increases on the PDS be-
tween initial assessment and the end of treatment. For 10 of the 14
patients (71.4%), the reliable increase had already occurred during
thewait period between the initial assessment and the ﬁrst session.
Thus, only 4 (1.2%) patients showed reliable exacerbation in
symptom severity during treatment.
Table 3
Hierarchical linear modeling: Estimates of random effects (patient, therapist) and ﬁxed effects (time, patient characteristics, therapist experience) on improvement in PTSD
symptoms with therapy.
Model 1 slope of
improvement and
random patient effects
Model 2 including
patient characteristics
Model 3 including random
therapist effects
Model 4 including
therapist experience
Overall ﬁt: AIC 6608.21 5967.25 5967.19 5951.56
Variance-covariance estimates for random parameters
Level 1: patient
Patient random intercept 66.46 (12.16)*** 41.09 (10.44)*** 37.41(11.22)*** 35.39 (11.85)**
Patient random slope 40.71 (6.87)*** 29.66 (5.49)*** 28.11 (5.49)*** 27.11 (5.46)***
Level 2: therapist
Therapist random intercept 1.88 (1.84) 1.69 (1.78)
Therapist random slope 0.79 (1.29) 1.02 (1.35)
Fixed effect estimates
Level 1: time effects
Intercept 11.00 (0.55)*** 18.90 (2.23)*** 18.89 (2.26)*** 18.50 (2.30)***
Linear time effect 24.88 (1.01)*** 18.33 (2.29)*** 18.63 (2.30)*** 19.23 (2.34)***
Quadratic time effect 8.42 (0.50)*** 8.38 (0.52)*** 8.35 (0.52)*** 8.36 (0.52)***
Level 2: patient characteristics
PTSD not main problem
- Nonspeciﬁc predictor 2.43 (1.37)(*) 2.28 (1.38) 2.11 (1.40)
- Moderator effect 0.71 (1.33) 0.79 (1.33) 0.44 (1.35)
Multiple traumas need treatment
- Nonspeciﬁc predictor 1.99 (1.50) 1.79 (1.49) 1.69 (1.51)
- Moderator effect 3.81 (1.38)** 3.66 (1.39)** 3.25 (1.40)*
Social problems
- Nonspeciﬁc predictor 3.26 (1.04)** 3.05 (1.04)** 3.17 (1.05)**
- Moderator effect 2.89 (0.94)** 2.79 (0.94)** 2.99 (0.96)**
No relationship
- Nonspeciﬁc predictor 0.14 (1.00) 0.08 (1.00) 0.02(1.00)
- Moderator effect 1.68 (0.92)(*) 1.70 (0.92)(*) 1.55 (0.93)(*)
Comorbid mood disorder
- Nonspeciﬁc predictor 5.85 (1.02)*** 5.79 (1.01)*** 5.79 (1.02)***
- Moderator effect 0.22 (0.94) 0.17 (0.94) 0.22 (0.94)
Suicide attempts
- Nonspeciﬁc predictor 0.87 (1.46) 0.95 (1.47) 0.95 (1.48)
- Moderator effect 1.31 (1.35) 1.33 (1.36) 1.37 (1.36)
History of substance dependence
- Nonspeciﬁc predictor 2.26 (1.32)(*) 2.39 (1.32)(*) 2.37 (1.32) (*)
- Moderator effect 1.76 (1.24) 1.77 (1.24) 1.84 (1.24)
Months since trauma
- Nonspeciﬁc predictor 0.59 (0.50) 0.64 (0.50) 0.60 (0.50)
- Moderator effect 0.59 (0.46) 0.59 (0.46) 0.66 (0.47)
Level 3: therapist effects
Staff therapist
- Nonspeciﬁc predictor 0.69 (1.49)
- Moderator effect 2.05 (1.37)
Experienced in CT-PTSD
- Nonspeciﬁc predictor 1.19 (1.24)
- Moderator effect 2.23 (1.15) (*)
***p < .001, **p < .01, *p < .05, (*) p < .10.
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Table 1 shows the changes in depressive (BDI) and anxiety (BAI)
symptoms with treatment. Patients showed large improvement in
these secondary outcomes.
Stability of treatment effects
Two thirds of the patients (n ¼ 220) provided follow-up data.
The mean duration of the follow-up was 280.1 days, SD ¼ 177.7.
There were no signiﬁcant changes in symptom scores between the
end of treatment and follow-up, PDS: F(1, 217) ¼ 1.01, p ¼ .317,
h2 ¼ 0.005; BDI: F(1, 211) ¼ 0.64, p ¼ .425, h2 ¼ 0.003; BAI, time
effect F(1, 212) ¼ 0.28, p ¼ .595, h2 ¼ 0.001.Moderators of treatment response
To reduce the number of potential predictors, candidate mod-
erators were ﬁrst considered individually (see Table 2). Few of the
RCT selection criteria, comorbidity, trauma and demographic
characteristics selected from the literature predicted outcome.
Signiﬁcant univariate moderation effects were found for 8 pre-
dictors: PTSD is not the main problem, patient needs treatment for
multiple traumas, social problems, relationship status, comorbid
mood disorder, history of suicide attempts, history of substance
dependence, longer time since the main trauma were associated
with somewhat less improvement. Several other variables pre-
dicted a greater overall severity of PTSD symptoms, but not the
slope of improvement (non-speciﬁc predictors). These included
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substance abuse, suicidal ideation, axis 1 disorder other than anx-
iety or mood disorder, comorbid personality disorder, chronic pain,
physical disability due to the trauma, history of major depression),
taking psychotropic medication, and a higher level of education.
Table 3 shows the results of the hierarchical modeling analyses
for four models of increasing complexity, which are shown in
separate columns. Overall model ﬁts and random effects for pa-
tients and therapists are shown at the top of the table, and ﬁxed
effects for candidate moderators and therapist variables at the
bottom. Model 1 (Level 1, random slopes and intercepts for patients
and improvement in PDS scores from pre treatment to post treat-
ment to follow-up and) showed highly signiﬁcant linear and
quadratic changes in PDS scores across assessment points, indi-
cating a steep decrease in PTSD symptoms with treatment, which
ﬂattened out during follow-up. Random slopes and intercepts for
patients were also highly signiﬁcant.
Model 2 added patient characteristics at Level 2; analysis was
restricted to the 8 candidate moderators that showed univariate
moderation effects. In the multivariate analysis, unique moderation
effects were found for needing treatment for multiple traumas and
social problems. Therewas a trend for relationship status. Comorbid
mood disorders and social problems were nonspeciﬁc predictors,
i.e., were associated with higher scores both at the beginning and
end of treatment. All other effects were nonsigniﬁcant.
Therapist effects
In Model 3 (Table 3) random intercepts and slopes were added
for therapists. There were no signiﬁcant random therapist effects,
and the results for patient characteristics were identical to Model 2.
Model 4 added two aspects of therapist experience (staff therapist,
experience with CT-PTSD) to the prediction. There was a trend for
inexperienced therapists to achieve somewhat less good outcome.
Association of moderators with treatment variables
Patients who needed treatment for multiple trauma were more
likely to attend irregularly than those who were treated for one or
two traumas, 33.3% versus 19.6%, c2 (1, n¼ 330)¼ 4.31, p¼ .038, but
did not differ in dropout rates or number of treatment sessions.
Their treatment was less trauma-focused than treatment of other
patients, M ¼ 1.46 (SD ¼ 0.37) versus M ¼ 1.33 (SD ¼ 0.40),
F(1,322) ¼ 4.28, p ¼ .039, h2 ¼ 0.013.
Patients who had social problems were more likely to drop out
of treatment, 18.5% versus 7.2%, c2 (1, n ¼ 327) ¼ 8.54, p ¼ .003.
Their treatment tended to be less trauma-focused than treatment
of other patients,M ¼ 1.39 (SD ¼ 0.42) versusM ¼ 1.30 (SD ¼ 0.36),
F(1,319) ¼ 3.432, p ¼ .065, h2 ¼ 0.011. Associations with unreliable
attendance (p. ¼ 0.105) and lower number of sessions (p ¼ .094)
failed to reach signiﬁcance.
Patients were more likely to drop out if the therapist was
inexperienced in delivering CT-PTSD, 18.1% versus 10.3%, c2 (1,
n ¼ 330) ¼ 4.15, p ¼ .042.
Discussion
The study supports the effectiveness of CT for PTSD in routine
clinical practice. It shows that this treatment can be successfully
implemented in a National Health Service clinic serving an ethni-
cally mixed urban catchment area, with therapists who ranged in
previous experience in CBT and in treating PTSD. The clinic’s
catchment area was clearly deﬁned, referral was by local family
doctors and community mental health teams, and a consecutive
sample was assessed, supporting the representativeness of theresults. The intent-to-treat analysis showed very large effect sizes
for improvement in PTSD symptoms with treatment. The effect size
estimates are conservative as training cases were included in the
analysis. The mean improvement in PTSD symptoms was large,
50.3% for the intent-to-treat sample, and 57.8% for completers, and
the majority of patients showed clinically signiﬁcant change, 57.3%
and 65.1% respectively. Depression and general anxiety symptoms
also showed substantial improvement with treatment.
Treatment was well tolerated. The overall dropout rate of 13.9%
was low, despite the fact that the clinic served a catchment area
characterized by high social deprivation and high mobility and that
some of the therapists were inexperienced in delivering the treat-
ment. It is below that observed in many RCTs (e.g., 34% Resick et al.,
2002; 43% Power et al., 2002; 34% Foa et al., 2005; 38% Schnurr et al,
2007; 26% Galovski, Blain, Mott, Elwood, & Houle, 2012) and
effectiveness studies of trauma-focused PTSD treatments (e.g., 36%
Levitt et al., 2007; 24% and 32%; van Minnen et al., 2002). Although
limited conclusions can be drawn from comparing dropout rates in
different samples across countries with different health systems, it
appears safe to conclude that the low dropout rates support the
acceptability of CT-PTSD to patients. This study further found that
patients who dropped out and those who attended irregularly had
poorer outcomes, so that limiting dropout rates is likely to improve
the overall effectiveness of interventions.
Consistent with previous studies (Foa et al., 2002; Hackmann
et al., 2004), symptom exacerbations were only found in a small
minority of patients. Interestingly, the results indicated that the
exacerbation mainly occurred between assessment and the start of
treatment. This result is similar to Duffy et al. (2007) who found
that deterioration was more common in the wait period than
during therapy. For the majority of patients, such symptom exac-
erbations may thus reﬂect the inﬂuence of other factors such as
new trauma or additional stressors rather than negative effects of
treatment per se.
This raises the question of what effect waiting for treatment
may have on the probability of engagement with treatment. The
average waiting time of about 3 months was relatively short for
psychological services in the UK National Health Service at the time
of the study. Overall, symptom scores were stable over the waiting
period. Some patients waited longer, partly due to the availability of
therapists and partly due to patient-determined factors such as
scheduled surgery/physical rehabilitation, work schedules, travel
or childbirth. It is unlikely that the wait for treatment contributed
to the relatively low dropout rates observed in this study as patients
who dropped out had waited longer than completers. This suggests
that it is desirable to reducewaiting times to help reduce the risk of
symptom deterioration and dropouts.
Effect sizes in the present study were comparable to those ob-
tained by Duffy et al. (2007) with the same treatment in an unse-
lected sample of patients with very chronic PTSD. The intent-to-
treat effect sizes were somewhat smaller than those observed in
some previous RCTs of CT-PTSD (Ehlers et al., 2003, 2005), but
similar to or larger than those observed in intent-to-treat analyses
in other RCTs of trauma-focused cognitive behavior therapy (Bryant
et al., 2003; Resick et al., 2002; Schnurr et al, 2007). Given that the
study reports on a consecutive intent-to-treat sample with a wide
range of traumas from an ethnically diverse and socially deprived
catchment area, and patients were treated by both trainees and
experienced clinicians, the outcomes can be considered as
encouraging.
The moderator analysis showed that many of the criteria that
have sometimes been used to exclude patients from RCTs were not
related to poorer outcome. The only exceptions were that patients
who needed treatment for multiple traumas and those for whom
PTSD was not the main clinical problem showed somewhat less
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effective in patients who do not meet all inclusion criteria for RCTs
and should not be withheld from these patients (see also van
Minnen et al., 2002).
Like other studies of TF-CBT programs (e.g., Richardson et al.,
2011; van Minnen et al., 2002), this study found few other mod-
erators of treatment response, further indicating that CT-PTSD is
effective in a wide range of patients. Most demographic variables
such as sex, age, ethnic group or education level were unrelated to
treatment response. This is consistent with the results of several
other studies (e.g., Richardson et al.., 2011; vanMinnen et al., 2002),
although some studies reported poorer outcome or larger drop-out
rates for men (Blain et al., 2010). It remains to be testedwhether the
differences in results are due to sample differences or differences in
procedures.
With the exception of mood disorders, current comorbidity did
not moderate outcome, but acted as a nonspeciﬁc predictor of
outcome only. High levels of depression were also associated with
less favorable outcome in Duffy et al. (2007) and Tarrier et al.
(2000), but not in other studies of TF-CBT (Ehlers et al., 2005;
Richardson et al., 2011; van Minnen et al., 2002). One possible
explanation for the discrepant results may be the range of
depression severity included in the studies. The studies that re-
ported negative ﬁndings had lower mean depression scores than
those ﬁnding an effect of depression. Comorbid depression may
only hamper progress in therapy if it is so severe that it affects daily
activity levels and motivation to engage in the therapy assign-
ments. The lack of a moderating effect of comorbid personality
disorders including borderline personality disorder is noteworthy
and consistent with other studies (Clarke et al., 2008; Feeny et al.,
2002).
Longer time since the trauma, a history of suicide attempts or
substance dependence, social problems, and relationship status
(never having been married or lived with a partner) were associ-
ated with a somewhat less favorable treatment response. The effect
of past suicide attempts replicates Tarrier et al.’s (2000) ﬁndings.
These characteristics, and possibly very high levels of depression,
may characterize a group of patients with high levels of demoral-
ization and hopelessness, who may not have been fully engaged in
treatment by their therapists. Time since the trauma has shown an
inconsistent pattern of associations with outcome. RCTs have
generally not found an effect (e.g., Ehlers et al., 2005; Resick et al.,
2002), although Schnurr et al (2007) concluded that the modest
treatment gains observed in their study may be related to the
extreme chronicity of their sample (M ¼ 23 years). Like the current
study, Duffy et al. (2007) also found that longer duration since the
traumawas associated with less favorable outcome. The differences
in results may also be linked to the wide range of traumas included
in the latter samples (for example, the inclusion of traumatic death
of signiﬁcant others), or the long-term effects of the trauma and/or
PTSD symptoms on important life areas such as employment, sig-
niﬁcant relationships or other resources (Hobfoll, 2002). The pre-
sent sample, like Duffy et al.’s (2007) included a high percentage of
patients with long-term loss of resources and signiﬁcant relation-
ships. Social problems and social isolation may make it harder to
overcome PTSD and may also create additional ongoing stress (see
also Galovski et al., 2012). The result that patients who had never
lived with a partner had somewhat worse outcome may also point
to a role of poor social support and interpersonal skills in the re-
covery from PTSD (see also Cloitre, Koenen, Cohen, & Han, 2002).
When the signiﬁcant moderators were considered together in a
multivariate analysis, only social problems and needing treatment
for multiple traumas emerged as unique moderators of outcome.
The associations of these moderators with treatment characteris-
tics suggest a doseeresponse effect. Treatment was less trauma-focused for these patients and signiﬁcant time in the sessions
was used to address other important problems such as comorbid
disorders or social problems such as problemswith state beneﬁts or
social housing, with a similar overall treatment duration of be-
tween 12 and 13 sessions. Patients with multiple trauma were less
reliable in attending sessions than other patients, and those with
social problemsweremore likely to drop out. This may have led to a
less than optimal dose of treatment for each of the patients’
traumas, and more treatment sessions may be necessary to further
improve outcome (see also National Institute for Health and Clinical
Excellence, 2005). For example, Galovski et al. (2012) found sig-
niﬁcant further treatment gains with cognitive processing therapy
for patients who had not fully responded by session 12. Therapists
may need to pay special attention to engaging these patients in
treatment. These patients may also beneﬁt from ancillary case
management services.
When therapists were included as a random factor in the hi-
erarchical linear model, no signiﬁcant effects on treatment
outcome were observed. This result is consistent with those of
other studies of patients with a particular disorder who were
treated with a deﬁned treatment protocol (Baldwin et al., 2011;
Cella et al., 2011; Kubany et al., 2004; Wilson et al., 2011), and
with Crits-Christoph et al.’s (1991) conclusion that the use of a
treatment manual reduces therapist effects. Studies of mixed pa-
tient samples treated by therapists of different theoretical orien-
tation have tended to show larger random effects of therapists, in
the range of 5e8% of the variance in outcome (Lutz et al., 2007;
Wampold & Brown, 2005). These results do not necessarily
contradict each other as smaller variation in treatment procedures
may restrict the variance due to individual therapists. In this study,
therapist experience with the speciﬁc treatment protocol showed a
trend for an association with somewhat better outcome, and
inexperienced therapists had more dropouts. This result is similar
to Duffy et al. (2007) who found that one reason for dropouts was
that some inexperienced therapists pushed patients into reliving
their trauma without adequately addressing their concerns ﬁrst.
Training programs and supervision for novice therapists need
attention on how to effectively engage patients with trauma
memory work.
The study had several limitations. First, the study did not have
an untreated control group and the results therefore cannot be
unambiguously interpreted as therapy effects. However, several
factors suggest that it is unlikely that the symptom changes rep-
resented natural recovery. Patients were referred to the clinic as
they were judged by health professionals to need professional help,
they had chronic, moderate to severe PTSD with a mean duration of
3 years, high comorbidity, and did not improve during the wait
period before treatment started. Second, the clinic focuses on PTSD
following trauma in adulthood and it remains unclear whether the
results generalize to patients whose main traumas were in child-
hood. However, a history of childhood abuse was not predictive of
poor outcome in this sample (see also Ford & Kidd, 1998). Third,
although data for the intent-to-treat analysis of treatment effects
were complete, the sample size was reduced at follow-up and it
remains unclear whether loss to follow-up was random. Fourth, we
did not have the resources to obtain ﬁdelity or therapist compe-
tency ratings from recordings of the therapy sessions. This may
have introduced error variance. However, the close supervision of
all cases ensured that therapists followed the protocol. The analysis
of session notes conﬁrmed that treatment sessions mainly focused
on the PTSD treatment protocol. Fifth, some of the 577 patients who
were referred to the clinic for an assessment were not suitable for
PTSD treatment at the time and were treated elsewhere. The most
common reasons were not having PTSD (n ¼ 42) and needing
treatment for another problem such as substance dependence or
A. Ehlers et al. / Behaviour Research and Therapy 51 (2013) 742e752 751immediate suicide risk ﬁrst (n ¼ 73). This pattern is to be expected
as General Practitioners in the UKNational Health Service have very
limited time for each consultation and may ask for specialist
assessment to determine the best care pathway for their patients.
Nevertheless, this pattern highlights the fact that not only RCTs, but
also routine clinical services have intake criteria and need to
exclude some patients, and that some of the reasons for why a
trauma-focused treatment is not offered may overlap. Sixth, the
sample size was modest for the investigation of therapist effects
and larger samples may be more sensitive in detecting therapist
variables that are associated with good outcome.
In conclusion, the results support the effectiveness of CT-PTSD in
a wide range of traumas and suggest that CT-PTSD can be suc-
cessfully implemented in the routine care of patients with PTSD.
Patients who need treatment for multiple traumas, severe comor-
bid disorders or social problems may beneﬁt from extending the
duration of treatment. Training new therapists in CT-PTSD or other
TF-CBT protocols may beneﬁt from special attention to engaging
patients with treatment to avoid dropouts.Acknowledgments
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